Facial plastic surgery clinics of North America | 2019
State-of-the-Art in Skin Cancer Surgery.
Abstract
Skin cancer remains the most common cancer in the United States, affecting approximately 20% of Americans during their lifetime. Despite major advances in care delivery, including targeted drug therapies and immunotherapy, the primary treatment for early nonmelanoma skin cancer (NMSC) and melanoma continues to be careful surgical extirpation with clear margins, along with meticulous reconstruction that optimally addresses functional and aesthetic deficits. The care of patients with skin cancers of the face is uniquely challenging, and this issue of Facial Plastic Surgery Clinics of North America addresses the contemporary management of facial NMSC and melanoma as well as up-todate reconstruction of the resultant defects. In cases of advanced skin cancer, adjuvant treatment is often required, and this issue reviews the tremendous advances in this area over the last 10 years. Looking to the future, the state of tissue engineering and 3D modeling is examined, along with the increasing role these technologies have in facial reconstructive surgery—they are becoming more refined and